Evaluation of the LACE+ Index for Short-Term Cardiac Surgery Outcomes: A Coarsened Exact Match Study.
The potential of LACE+ scores, in patients undergoing cardiac surgery, to predict short-term undesirable outcomes was examined. Coarsened exact matching was used to assess the predictive capacity of the LACE+ index amongst all cardiac surgery cases over a two-year period (2016-2018) at one health system (n=4001). Study subjects were matched on characteristics not assessed by LACE+, including duration of surgery, wound class, BMI, insurance type, median household income, and race amongst others. For comparison of outcomes, LACE score was divided into quartiles and otherwise matched populations were compared in reference to LACE quartile: Q4 vs Q1, Q4 vs Q2, Q4 vs Q3. Escalating LACE+ score significantly predicted increased readmission (6.99% vs 25.92% for Q1 vs Q4, 12.79% vs 26.74% for Q2 vs Q4, and 20.52% vs 27.66% for Q3 vs Q4, respectively; p < 0.001, p < 0.001, p = 0.003), reoperation (2.39% vs 7.73% for Q1 vs Q4, 4.33% vs 7.67% for Q2 vs Q4, respectively; p < 0.001, p = 0.015), and ER visits at 30 days postop (6.64% vs 13.65% for Q1 vs Q4, 11.20% vs 14.84% for Q2 vs Q4, respectively; p < 0.001, p = 0.041) as well as readmission, reoperation, and ER visits from 30-90 days postop and 0-90 days postop. Increasing LACE score predicted higher rates of death over follow up within 30 and 90 postoperative days (p < 0.001). The LACE+ index may be suitable as a prediction model for important patient outcomes in a cardiac surgery population.